These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25366661)

  • 1. Humanized mouse models for HIV-1 infection of the CNS.
    Honeycutt JB; Sheridan PA; Matsushima GK; Garcia JV
    J Neurovirol; 2015 Jun; 21(3):301-9. PubMed ID: 25366661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized mice: models for evaluating NeuroHIV and cure strategies.
    Honeycutt JB; Garcia JV
    J Neurovirol; 2018 Apr; 24(2):185-191. PubMed ID: 28831774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?
    Gorantla S; Gendelman HE; Poluektova LY
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):352-62. PubMed ID: 22222956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND).
    Zayyad Z; Spudich S
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):16-24. PubMed ID: 25604237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models for depression associated with HIV-1 infection.
    Barreto IC; Viegas P; Ziff EB; Konkiewitz EC
    J Neuroimmune Pharmacol; 2014 Mar; 9(2):195-208. PubMed ID: 24338381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease.
    Zink MC; Clements JE
    J Neurovirol; 2002 Dec; 8 Suppl 2():42-8. PubMed ID: 12491150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses.
    Gillgrass A; Wessels JM; Yang JX; Kaushic C
    Front Immunol; 2020; 11():617516. PubMed ID: 33746940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
    Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
    PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir.
    Mukhtar M; Duke H; BouHamdan M; Pomerantz RJ
    Hum Gene Ther; 2000 Jan; 11(2):347-59. PubMed ID: 10680847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV pharmacology: barriers to the eradication of HIV from the CNS.
    McGee B; Smith N; Aweeka F
    HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic models of HIV-1.
    Klotman PE; Rappaport J; Ray P; Kopp JB; Franks R; Bruggeman LA; Notkins AL
    AIDS; 1995 Apr; 9(4):313-24. PubMed ID: 7794536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 in the developing CNS: developmental differences in gene expression.
    Buzy JM; Lindstrom LM; Zink MC; Clements JE
    Virology; 1995 Jul; 210(2):361-71. PubMed ID: 7618273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.